ViewRay Inc
OTC:VRAYQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SamsungFN REIT Co Ltd
KRX:448730
|
KR |
|
Melco Holdings Inc
TSE:6676
|
JP |
|
Novocure Ltd
NASDAQ:NVCR
|
JE |
|
Clicks Group Ltd
OTC:CLCGY
|
ZA |
|
S
|
Scryb Inc
CNSX:SCYB
|
CA |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
ViewRay Inc
OTC:VRAYQ
|
183 USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.7B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.1B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
ViewRay Inc
Glance View
ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. The company is headquartered in Oakwood Village, Ohio and currently employs 267 full-time employees. The company went IPO on 2014-11-04. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumor from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The firm has installed approximately 48 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for ViewRay Inc is 8%, which is in line with its 3-year median of 8%.
Over the last 3 years, ViewRay Inc’s Gross Margin has increased from -2.7% to 8%. During this period, it reached a low of -14.8% on Sep 30, 2020 and a high of 9.8% on Dec 31, 2022.
